Have a feature idea you'd love to see implemented?
Let us know!
HLVX HilleVax Inc
Price (delayed)
$1.82
Market cap
$90.65M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$3.1
Enterprise value
$10.23M
Highlights
HLVX's debt has dropped by 51% since the previous quarter and by 51% year-on-year
HLVX's quick ratio has soared by 175% since the previous quarter but it is down by 20% year-on-year
HilleVax's net income has decreased by 39% YoY but it has increased by 3.8% QoQ
The equity has declined by 38% year-on-year and by 10% since the previous quarter
Key stats
What are the main financial stats of HLVX
Market
Valuations
Earnings
Shares outstanding
49.81M
Market cap
$90.65M
Enterprise value
$10.23M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.49
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$146.24M
EBITDA
-$143.17M
Free cash flow
-$113.36M
Per share
Balance sheet
Liquidity
EPS
-$3.1
Free cash flow per share
-$2.3
Book value per share
$3.7
Revenue per share
$0
TBVPS
$4.47
Total assets
$220.62M
Total liabilities
$36.35M
Debt
$24.97M
Equity
$184.27M
Working capital
$183.33M
Debt to equity
0.14
Current ratio
14.25
Quick ratio
13.8
Net debt/EBITDA
0.56
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-52%
Return on equity
-67.3%
Return on invested capital
-91.4%
Return on capital employed
-70.7%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
HLVX stock price
How has the HilleVax stock price performed over time
Intraday
1.68%
1 week
-3.7%
1 month
-0.55%
1 year
-86.72%
YTD
-88.66%
QTD
3.41%
Financial performance
How have HilleVax's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$159.43M
Net income
-$150.28M
Gross margin
N/A
Net margin
N/A
HilleVax's net income has decreased by 39% YoY but it has increased by 3.8% QoQ
HilleVax's operating income has decreased by 37% YoY but it has increased by 4.5% QoQ
Growth
What is HilleVax's growth rate over time
Valuation
What is HilleVax stock price valuation
P/E
N/A
P/B
0.49
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
HLVX's EPS is down by 35% year-on-year but it is up by 9% since the previous quarter
HLVX's price to book (P/B) is 81% less than its last 4 quarters average of 2.6
The equity has declined by 38% year-on-year and by 10% since the previous quarter
Efficiency
How efficient is HilleVax business performance
HilleVax's ROE has plunged by 60% YoY and by 9% from the previous quarter
The return on assets has dropped by 53% year-on-year and by 8% since the previous quarter
The ROIC has contracted by 4.7% from the previous quarter
Dividends
What is HLVX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for HLVX.
Financial health
How did HilleVax financials performed over time
The company's current ratio has surged by 177% QoQ but it fell by 19% YoY
HLVX's quick ratio has soared by 175% since the previous quarter but it is down by 20% year-on-year
HLVX's debt is 86% smaller than its equity
HLVX's debt has dropped by 51% since the previous quarter and by 51% year-on-year
The debt to equity has declined by 44% since the previous quarter and by 18% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.